en

PRODUCT DETAIL

Beyfortus 50 mg injekčný roztok v naplnenej injekčnej striekačke

Code 2461E
MA number EU/1/22/1689/001
Product Form: sol inj 1x0,5 ml/50 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J06 IMMUNE SERA AND IMMUNOGLOBULINS
J06B IMMUNOGLOBULINS
J06BD Antiviral monoclonal antibodies
J06BD08 Nirsevimab
Shelf life: 15
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 31.10.2022
Validity: 31.10.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 02.12.2022
eu-flag.png sk-flag.png